Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001140361-26-011373
Filing Date
2026-03-26
Accepted
2026-03-26 16:24:06
Documents
2
X0202

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13D/A  
1 primary_doc.xml SCHEDULE 13D/A 9878
2 EXHIBIT 99.6 ef20068661_99-6.htm EX-99 32121
  Complete submission text file 0001140361-26-011373.txt   43621
Mailing Address 1901 W. 47TH PLACE KANSAS CITY KS 66205
Business Address 1901 W. 47TH PLACE KANSAS CITY KS 66205 (913) 942-2300
Cingulate Inc. (Subject) CIK: 0001862150 (see all company filings)

EIN.: 863825535 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13D/A | Act: 34 | File No.: 005-93147 | Film No.: 26798602
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 21 STRATHMORE ROAD NATICK MA 01769
Business Address 21 STRATHMORE ROAD NATICK MA 01769 617.899.8849
Falcon Creek Capital Advisor LLC (Filed by) CIK: 0002106999 (see all company filings)

EIN.: 842967889 | State of Incorp.: IL | Fiscal Year End: 1231
Type: SCHEDULE 13D/A